Skip to content
About
Clinical Trials
Resources
Contact
About
Clinical Trials
Resources
Contact
A011801
A011801 Compass HER2RD: a double-blinded, phase III, randomized trial of T-DM1 compared with T-DM1 and Tucatinib
Status:
Open
Trial Type:
Breast Cancer
Contact:
William Sikov, MD
wsikov@wihri.org
